Clinical Trial Update: Efficacy and Safety of Formulation Switching Between SC Infliximab and IV Infliximab in Patients With CD [NA]

View source ↗

Summary

This clinical trial update outlines a study evaluating switching between subcutaneous and intravenous infliximab in Crohn's disease patients to assess efficacy …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Infliximab (infliximab)

Snippet

Sponsor: Asan Medical Center | Conditions: Crohn's Disease | NA | Status: RECRUITING